Simplify Logo

Full-Time

Technical Accounting Associate Director

Posted on 5/15/2024

GRAIL

GRAIL

1,001-5,000 employees

Develops blood tests for early cancer detection

Data & Analytics
Hardware
Financial Services
Biotechnology
Healthcare

Compensation Overview

$159k - $199kAnnually

+ Bonus + Long-term Incentive Plans

Expert

Menlo Park, CA, USA

Category
Financial Accounting
Accounting
Required Skills
NetSuite
Requirements
  • At least 12 years of highly technical accounting experience
  • BA/BS degree in Accounting with an active US CPA certification
  • Strong knowledge of US GAAP
  • Experience in reporting to internal and external stakeholders
  • Ability to lead complex projects
  • Experience with specific accounting standards like ASC 230, ASC 718, ASC 350, ASC 842, ASC 606, ASC 805, ASC 350-40
  • Experience with NetSuite, Workiva, Floqast, and Intelligize is a plus
Responsibilities
  • Interface with Management on complex technical accounting matters
  • Research technical accounting issues and present conclusions to Management
  • Monitor current accounting and reporting trends
  • Lead efforts to implement new accounting pronouncements
  • Prepare internal and external accounting/reporting documents
  • Adhere to review and filing deadlines
  • Support annual audit and quarterly reviews
  • Lead and participate in special projects

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by conducting large-scale clinical studies to ensure the effectiveness and reliability of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Company Stage

M&A

Total Funding

$11B

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

3%

1 year growth

7%

2 year growth

15%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful completion of large-scale clinical trials like PATHFINDER 2 and NHS-Galleri could solidify GRAIL's reputation and lead to widespread adoption of its Galleri test.
  • Partnerships with healthcare providers like CarePoint and WVU Medicine enhance GRAIL's market penetration and credibility in the healthcare sector.
  • The spin-off from Illumina and potential listing on Nasdaq could provide GRAIL with increased financial resources and market visibility.

What critics are saying

  • The high cost and complexity of large-scale clinical trials could strain GRAIL's financial resources and delay product rollouts.
  • Dependence on partnerships and collaborations for market penetration may limit GRAIL's control over its growth trajectory.

What makes GRAIL unique

  • GRAIL leverages high-intensity sequencing and deep learning to analyze vast amounts of tumor genome data, setting it apart from traditional cancer detection methods.
  • The company's focus on large-scale clinical studies, such as PATHFINDER 2 and NHS-Galleri, ensures robust clinical validation and performance evidence for its Galleri test.
  • GRAIL's potential to expand into direct-to-consumer sales could significantly broaden its market reach, unlike many competitors who remain focused on B2B models.

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.

Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.

Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.

Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

INACTIVE